Table A2.

Survival Rates

Stage	All					RT Plus Cisplatin					RT Plus Other
	No. of Patients	2-Year PFS		5-Year OS		No. of Patients	2-Year PFS		5-Year OS		No. of Patients	2-Year PFS		5-Year OS
		%	95% CI	%	95% CI		%	95% CI	%	95% CI		%	95% CI	%	95% CI
IB	410	73	69 to 78	72	68 to 77	235	79	74 to 84	78	72 to 83	175	65	59 to 73	66	59 to 73
IIA	23	77	61 to 97	72	54 to 97	23	77	61 to 97	72	54 to 97	—	—		—
IIB	960	69	66 to 72	63	59 to 66	632	73	70 to 77	68	64 to 72	328	61	56 to 66	53	48 to 59
IIIA	23	28	14 to 55	27	14 to 54	12	46	24 to 87	46	24 to 87	11	9	1 to 59	9	1 to 59
IIIB	566	53	49 to 57	48	44 to 52	384	57	52 to 62	52	47 to 57	182	44	37 to 52	38	32 to 46
IVA	60	27	18 to 41	35	24 to 50	39	27	16 to 45	34	21 to 54	21	29	15 to 56	37	21 to 65

Abbreviations: OS, overall survival; PFS, progression-free survival; RT, radiotherapy.